vancomycin has been researched along with Candidiasis, Invasive in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Belkaid, Y; Bending, D; Collins, N; Conlan, S; Deming, C; Desai, JV; Drummond, RA; Green, NM; Lecky, D; Lee, CR; Lionakis, MS; Matei-Rascu, V; Prevots, DR; Quinones, M; Ricotta, EE; Segre, JA; Sherif, L; Swamydas, M; Withers, D; Zelazny, AM | 1 |
Ellis, DB; Weimer, JM | 1 |
2 other study(ies) available for vancomycin and Candidiasis, Invasive
Article | Year |
---|---|
Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Candida albicans; Candidiasis, Invasive; Coinfection; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Iatrogenic Disease; Immunotherapy; Interleukin-17; Mice; Th17 Cells; Vancomycin | 2022 |
Superbug Meets Opportunistic Infection: A Case Report of Mobilized Colistin Resistance-1-Positive Klebsiella pneumoniae and Candida lusitaniae in a Complex Surgical Patient.
Topics: Candidiasis, Invasive; Cilastatin, Imipenem Drug Combination; Coinfection; Drug Resistance, Multiple, Bacterial; Gastrointestinal Hemorrhage; Humans; Intestinal Fistula; Klebsiella Infections; Klebsiella pneumoniae; Male; Micafungin; Middle Aged; Pancreatitis, Acute Necrotizing; Treatment Outcome; Vancomycin | 2019 |